O-2050

• Supplier: R&D Systems
• Catalog: 1655
• Prices: $269.00
• Sizes: 10 mg
• Cas Number: 851320-29-1
• Chemical Name: (6aR,10aR)-1-Hydroxy-3-(1-Methanesulfonylamino-4-hexyn-6-yl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran
• Formula: C23H31NO4S
• Molecular Weight: 417.56
• Purity: >97%

Product References

Endocannabinoids modulate cortical development by configuring Slit2/Robo1 - Endocannabinoids modulate cortical development by configuring Slit2/Robo1

Alpar A, Tortoriello G, Calvigioni D, Niphakis MJ, Milenkovic I, Bakker J, Cameron GA, Hanics J, Morris CV, Fuzik J, Kovacs GG, Cravatt BF, Parnavelas JG, Andrews WD, Hurd YL, Keimpema E, Harkany T. Nat Commun. 2014 Jul 17;5:4421.

CB1 and CB2 receptors are novel molecular targets for Tamoxifen and - CB1 and CB2 receptors are novel molecular targets for Tamoxifen and

Prather PL, FrancisDevaraj F, Dates CR, Greer AK, Bratton SM, Ford BM, Franks LN, Radominska-Pandya A. Biochem Biophys Res Commun. 2013 Nov 15;441(2):339-43. doi:

Diacylglycerol lipase alpha manipulation reveals developmental roles for - Diacylglycerol lipase alpha manipulation reveals developmental roles for

Keimpema E, Alpar A, Howell F, Malenczyk K, Hobbs C, Hurd YL, Watanabe M, Sakimura K, Kano M, Doherty P, Harkany T. Sci Rep. 2013;3:2093.

CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin - CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin

Malenczyk K, Jazurek M, Keimpema E, Silvestri C, Janikiewicz J, Mackie K, Di Marzo V, Redowicz MJ, Harkany T, Dobrzyn A. J Biol Chem. 2013 Nov 8;288(45):32685-99.

Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain - Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain

Brents LK, Gallus-Zawada A, Radominska-Pandya A, Vasiljevik T, Prisinzano TE, Fantegrossi WE, Moran JH, Prather PL. Biochem Pharmacol. 2012 Apr 1;83(7):952-61.

Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids - Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids

Chimalakonda KC, Seely KA, Bratton SM, Brents LK, Moran CL, Endres GW, James LP, Hollenberg PF, Prather PL, Radominska-Pandya A, Moran JH. Drug Metab Dispos. 2012 Nov;40(11):2174-84.

Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain - Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain

Brents LK, Reichard EE, Zimmerman SM, Moran JH, Fantegrossi WE, Prather PL. PLoS One. 2011;6(7):e21917.